noberastine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2000
01219912000

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2000
Review
2000
BACKGROUND We studied H1 antihistaminic safety, with respect to CNS, and clinical trial validity to determine its adverse effects… (More)
Is this relevant?
1995
1995
Histamine H1 receptor antagonists (antihistamines) are particularly useful in the management of exudative types of allergic… (More)
  • figure 1
Is this relevant?
Review
1995
Review
1995
Histamine H1-receptor antagonists are reversible, competitive inhibitors of the actions of histamine, a critical mediator in the… (More)
Is this relevant?
1993
1993
1. The time course and magnitude of effect of the novel H1-receptor antagonist noberastine, structurally modified from astemizole… (More)
Is this relevant?
1991
1991
Noberastine (NOB), a new histamine H1 antagonist, has potent and specific peripheral antihistaminic activity. To evaluate the… (More)
Is this relevant?
1991
1991
The antihistaminic effects of 7 days treatment with each of three doses of noberastine (10, 20 and 30 mg) were compared to… (More)
  • table 1
  • figure 1
Is this relevant?